Genetic determinants of aggressive breast cancer.

作者: Alejandra C. Ventura , Sofia D. Merajver

DOI: 10.1146/ANNUREV.MED.59.060106.184830

关键词:

摘要: The development and spread of breast other human cancers are caused by the overexpression, mutation, and/or deletion specific genes that drive these events. Finding genetic molecular differences between cancerous healthy cells can reveal determinants cancer. This knowledge results in a better understanding carcinogenic process improved predictive power, with implications for identifying new drug targets, designing novel therapies, improving preclinical clinical studies. We review concepts biomarker, marker, determinant cancer, particular focus on most aggressive lethal form termed inflammatory cancer (IBC). Using IBC as an example, we describe detail approaches to identify responsible for—and not merely associated with—this disease.

参考文章(68)
Christopher Sears, Scott A. Armstrong, Microarrays to identify new therapeutic strategies for cancer. Advances in Cancer Research. ,vol. 96, pp. 51- 74 ,(2006) , 10.1016/S0065-230X(06)96003-5
M. Kaufmann, Review of Known Prognostic Variables Adjuvant Therapy of Breast Cancer V. ,vol. 140, pp. 77- 87 ,(1996) , 10.1007/978-3-642-79278-6_10
C Gamallo, P Navarro, A Suarez, A Cano, M Quintanilla, J Palacios, A Pizarro, Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. American Journal of Pathology. ,vol. 142, pp. 987- 993 ,(1993)
P Adamson, C.J. Marshall, A Hall, P.A. Tilbrook, Post-translational modifications of p21rho proteins. Journal of Biological Chemistry. ,vol. 267, pp. 20033- 20038 ,(1992) , 10.1016/S0021-9258(19)88661-1
Celina G. Kleer, Kenneth L. van Golen, Yanhong Zhang, Zhi-Fen Wu, Mark A. Rubin, Sofia D. Merajver, Characterization of RhoC expression in benign and malignant breast disease: A potential new marker for small breast carcinomas with metastatic ability American Journal of Pathology. ,vol. 160, pp. 579- 584 ,(2002) , 10.1016/S0002-9440(10)64877-8
Bert Vogelstein, Kenneth W. Kinzler, The Genetic Basis of Human Cancer ,(1997)
Jennifer R. Hurvitz, Wafaa M. Suwairi, Wim Van Hul, Hatem El-Shanti, Andrea Superti-Furga, Jean Roudier, Daniel Holderbaum, Richard M. Pauli, J. Kenneth Herd, Els Van Hul, Hossien Rezai-Delui, Eric Legius, Martine Le Merrer, Jamil Al-Alami, Sultan A. Bahabri, Matthew L. Warman, Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nature Genetics. ,vol. 23, pp. 94- 98 ,(1999) , 10.1038/12699
Saïd M. Sebti, Andrew D. Hamilton, Inhibition of Rho GTPases using protein geranylgeranyltransferase I inhibitors. Methods in Enzymology. ,vol. 325, pp. 381- 388 ,(2000) , 10.1016/S0076-6879(00)25459-1